Role of 18F-dopa PET/CT imaging in the management of patients with 111In-pentetreotide negative GEP tumours-Reference-Cited by-同舟云学术

Role of 18F-dopa PET/CT imaging in the management of patients with 111In-pentetreotide negative GEP tumours

Published:2007-06 Issue:6 Volume:28 Page:473-477
ISSN:0143-3636
Container-title:Nuclear Medicine Communications
language:en
Short-container-title:

Author:

Ambrosini Valentina,Tomassetti Paola,Rubello Domenico,Campana Davide,Nanni Cristina,Castellucci Paolo,Farsad Mohsen,Montini Giancarlo,Al-Nahhas Adil,Franchi Roberto,Fanti Stefano

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Reference20 articles.

1. Current status of gastrointestinal carcinoids;Modlin;Gastroenterology,2005

2. A 5-decade analysis of 13,715 carcinoid tumors;Modlin;Cancer,2003

3. Incidence and management of malignant digestive endocrine tumours in a well defined French population;Lepage;Gut,2004

4. Epidemiology of neuroendocrine tumours;Taal;Neuroendocrinology,2004

5. Cancer Medicine;Vinik,1993

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular imaging of a glucagonoma with 18F-FDG PET/CT and 68Ga-DOTATATE PET/CT imaging: A case report and review of the literature;Radiology Case Reports;2020-01

2. Role of Functional Imaging in the Diagnosis of Neuroendocrine Tumors;Updates in Surgery;2018

3. The Added Diagnostic Value of 18F-Fluorodihydroxyphenylalanine PET/CT in the Preoperative Work-Up of Small Bowel Neuroendocrine Tumors;Journal of Gastrointestinal Surgery;2017-12-12

4. Multislice PET/CT in Neuroendocrine Tumors;Multislice CT;2017

5. Molecular Imaging of Somatostatin Receptor-Positive Tumors Using PET/CT;Somatostatin Analogues;2015-06-05